ꢀ
J. L. Garcıa Ruano et al. / Tetrahedron Letters 45 (2004) 4653–4656
4656
ꢀ
5. (a) Garcıa Ruano, J. L.; Cid, B. Top. Curr. Chem. 1999,
204, 1–126 (Organosulfur Chemistry I); (b) Garcıa Ruano,
In summary, we have demonstrated the high efficiency
of the reactions of 11H-dibenzo[b,e]azepine-5 oxide (1)
with the sulfinylfuranones 2a and 2b in the asymmetric
synthesis of highly functionalized isoxazoloazepines and
pyrroloazepines. The significant role of the sulfinyl
group improving the dipolarophilic features of the
5-alkoxy-3-furanones is also evident from the results
herein presented.
ꢀ
~
J. L.; Carreno, M. C.; Toledo, M. A.; Aguirre, J. M.;
Aranda, M. T. Angew. Chem., Int. Ed. 2000, 39, 2736–
ꢀ
2737; (c) Garcıa Ruano, J. L.; Aleman, J.; Soriano, J. F.
Org. Lett. 2003, 5, 677–680; Garcıa Ruano, J. L.; Aleman,
ꢀ
ꢀ
ꢀ
ꢀ
J. Org. Lett. 2003, 5, 4513–4516; (d) Garcıa Ruano, J. L.;
Alemparte, C. J. Org. Chem. 2004, 69, 1405–1408.
ꢀ
6. Carretero, J. C.; Garcıa Ruano, J. L.; Lorente, A.; Yuste,
F. Tetrahedron: Asymmetry 1993, 2, 177–180.
ꢀ
7. (a) Garcıa Ruano, J. L.; Fraile, A.; Martın, M. R.
Tetrahedron: Asymmetry 1996, 7, 1943–1950; (b) Garcıa
ꢀ
ꢀ
ꢀ
ꢀ
Ruano, J. L.; Fraile, A.; Gonzalez, G.; Martın, M. R.;
Clemente, F. R.; Gordillo, R. J. Org. Chem. 2003, 68,
6522–6534.
Supplementary material
Experimental procedures as well as spectroscopic data
of compound 3–5, 7–8 and 11 are available. This
material is available online with the paper in Science-
Direct.
ꢀ
ꢀ
8. Garcıa Ruano, J. L.; Fraile, A.; Martın, M. R. Tetrahe-
dron 1999, 55, 14491–14500.
ꢀ
9. (a) Garcıa Ruano J. L.; Fraile, A.; Martın, M. R. In 19th
International Symposium Organic Chemistry of Sulfur,
ꢀ
ꢀ
Book of Abstracts, 2000; pp 26; (b) Garcıa Ruano, J. L.;
Tito, A.; Peromingo, M. T. J. Org. Chem. 2003, 68, 10013–
ꢀ
10019; (c) Garcıa Ruano, J. L.; Tito, A.; Peromingo, M. T.
J. Org. Chem. 2002, 67, 981–987.
Acknowledgements
ꢀ
10. (a) Louis, C.; Hootele, C. Tetrahedron: Asymmetry 1997,
8, 109–131, and references cited therein; (b) Aggarwal, V.
K.; Roseblade, S.; Barrell, J. K.; Alexander, K. Org. Lett.
2002, 4, 1227–1229.
We thank CAICYT (Grant BQU2003-04012) and
Janssen-Cilag, S.A. for financial support.
11. Rispens, M. T.; Keller, E.; de Lange, B.; Zijlstra, W. J.;
Feringa, B. L. Tetrahedron Asymmetry 1994, 4, 607–624,
and references cited therein.
12. The syn- or anti-character of the adducts that indicates the
cis- or trans-relationship between H3 and H3a (Scheme 2),
is related to the face of the dipolarophile, which is attacked
by the dipole, using as a reference the spatial arrangement
of the ethoxy group. The endo- or exo-terms, indicative of
the cis- or trans-arrangement exhibited by furanone and
azepine moieties at the isoxazolidine ring, are related to
the endo- and exo-addition modes of the dipole, using the
ester group at the furanone ring as a reference.
References and notes
1. (a) Guzikowski, A. P.; Espitia, S. A.; Hawkinson, J. E.;
Huettner, J. E.; Nogales, D. F.; Wodward, R. M.; Weber,
E.; Keana, C. J. Med. Chem. 1996, 39, 4643–4653,
and references cited therein; (b) Link, A.; Kunick, C.
J. Med. Chem. 1998, 41, 1299–1305, and references cited
therein.
ꢀ
2. (a) Andres, J. I.; Alcazar, J.; Alonso, J. M.; Dıaz, A.;
Fernandez, J.; Gil, P.; Iturrino, L.; Matesanz, E.; Meert,
ꢀ
ꢀ
13. (a) Merenda, I.; Ottana, R.; Romeo, G.; Rotondo, E.
Heterocycles 1989, 29, 547–555; (b) Burdisco, M.; Gamba,
A.; Gandolfi, R.; Pevarelo, P. Tetrahedron 1988, 44, 3735–
3748.
14. Crystallographic data (excluding structure factors) for
anti-3a-endo have been deposited with the Cambridge
Crystallographic Data Centre as suplementary publication
number CCDC 190809. Copies of the data can be
obtained, free of charge, on application to CCDC, 12
Union Road, Cambridge CB2 1EZ, UK [fax: +44(0)-1223-
ꢀ
T. F.; Megens, A.; Sipido, V. K. Bioorg. Med. Chem. Lett.
ꢀ
2002, 12, 243–248; (b) Andres, J. I.; Alcazar, J.; Alonso, J.
M.; Diaz, A.; Fernandez, J.; Gil, P.; Iturrino, L.; Mate-
ꢀ
ꢀ
sanz, E.; Meert, T. F.; Megens, A.; Sipido, V. K. Bioorg.
Med. Chem. Lett. 2002, 12, 249–253.
3. (a) Nickolson, V. J.; Wieringa, J. H. J. Pharm. Pharmacol.
1981, 33, 760–766; (b) Mizuno, A.; Miya, M.; Kamei, T.;
Shibata, M.; Tatsuoka, T.; Nakanishi, K.; Takiguchi, C.;
Hidaka, T.; Yamaki, A.; Inomata, N. Chem. Pharm. Bull.
2000, 48, 1129–1137; (c) Mizuno, A.; Shibata, M.;
Iwamori, T.; Shimamoto, T.; Nakanishi, K.; Inomata,
N. U.S. Patent No 875, 495, 2001; Chem. Abstr. 2001, 135,
92553.
4. (a) Tufariello, J. J. In 1,3-Dipolar Cycloaddition Chemistry;
Padwa, A., Ed.; John Wiley & Sons: New York, 1984; Vol.
2, pp 83–168; (b) Frederickson, M. Tetrahedron 1997, 53,
403–425; (c) Gothelf, K. V.; Jørgensen, K. A. Chem. Rev.
1998, 98, 863–909.
15. Schenck, G. O. Liebigs Ann. 1953, 584, 156–176.
16. (a) Tufariello, J. J.; Tette, J. J. Org. Chem. 1975, 40, 3866–
ꢀꢁ
ꢁ
ꢁ
€
3869; (b) Kuban, J.; Kolarovic, A.; Fisera, L.; Jager, V.;
ꢀ
ꢀ
Humpa, O.; Pronayova, N. Synlett 2001, 1866–1868.
17. The in vitro screening of the compounds was performed at
Johnson & Johnson Pharmaceutical Research & Develop-
ment, Division of Janssen Pharmaceutica N.V., Turnh-
outsweg 30, B2340 Beerse, Belgium. The authors would
like to acknowledge support from this company.